Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Website

<< Previous

Bullboard Posts

Next >>

Comment by Pareto8020on Aug 04, 2023 1:33pm

151 Views

Post# 35573726

RE:RE:RE:RE:Website

Looks like they've posted an August Investor Presentation.

https://www.sironabiochem.com/wp-content/uploads/2023/08/Sirona-Corporate-Deck-Aug-2023.pdf

And for the love of god can they take down the video of Howard and Hopton walking around the lab looking awkward? Promote the science upfront not the knobs mismanaging the company - talk about ego's. Cause that's what everyone wants to see going onto the SBM website is the CEO and CFO's dumb mugs walking around a lab.

<< Previous

Bullboard Posts

Next >>

Osisko Development receives permits for Cariboo Gold Project